-
Clinical Ophthalmology
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Primary localized conjunctival amyloidosis: A case report with a ten-year follow-up period
Case report
(2643) Views (691) Full article downloads
Authors: Juan Carlos Mesa-Gutiérrez, Tomás Martí Huguet, Noemí Barnils Garcia, Jorge Arruga Ginebreda
Published Date October 2008
Volume 2008:2(3) Pages 685 - 687
DOI: http://dx.doi.org/10.2147/OPTH.S2884
Juan Carlos Mesa-Gutiérrez, Tomás Martí Huguet, Noemí Barnils Garcia, Jorge Arruga Ginebreda
Department of Ophthalmology, Hospital Universitari de Bellvitge, L’Hospitalet de Llobregat, Barcelona, Spain
Abstract: A 57-year-old woman consulted our department about a plaque that had been present in her left eye for one year. Ophthalmological examination revealed a solid mass in the left conjunctival semilunar fold. An excitional biopsy was peformed, revealing an amyloid deposition. The patient was referred to the Internal Medicine Department for systemic study. All studies were negative for systemic amyloidosis. Throughout ten years of follow-up study, the patient has shown neither conjunctival recurrence nor any evidence of systemic amylodosis. Despite the fact that several authors have described ocular amyloidosis as an ophthalmologic manifestation of systemic amyloidosis, conjunctival location of amyloidosis is a very rare condition. Amyloid characterization in ocular structures should not be considered a final diagnosis since involvement of systemic underlying diseases must be ruled out. We report a case of localized conjunctival amyloidosis with a ten-year follow-up period that excluded ocular or systemic diseases.
Keywords: conjuctival amyloidosis, ocular amyloidosis, hyaline protein
Other articles by Dr Juan Mesa-Gutierrez
Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to retinal vein occlusion
Optic nerve sheath meningocele
Readers of this article also read:
Delayed release pancrelipase for treatment of pancreatic exocrine insufficiency associated with chronic pancreatitis
Helicopter emergency medical services accident rates in different international air rescue systems
Impact of comorbidities and drug therapy on development of renal impairment in a predominantly African American and Hispanic HIV clinic population
Subgroup analysis of large trials can guide further research: a case study of vitamin E and pneumonia
Efficacy and tolerability of the fixed combination of brinzolamide 1% and timolol 0.5% in daily practice
Erratum
Efficacy and safety of bazedoxifene for postmenopausal osteoporosis
Corrigendum
Corrigendum
- Journal Indexing
See where all the Dove Press journals are indexed
- Interested in being a peer-reviewer?
Click here to register.
- Insight into 144 patients with ocular vascular events during VEGF antagonist injections
- Endophthalmitis: Pathogenesis, clinical presentation, management, and perspectives
- Protection of neurons in the retinal ganglion cell layer against excitotoxicity by the N-acylethanolamine, N-linoleoylethanolamine
- A computer-based anaglyphic system for the treatment of amblyopia




